506U78 In Relapsed Or Refractory Acute Lymphoblastic Leukemia (T-ALL)
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Nelarabine is effective in the treatment of
patients with T-ALL/NHL in order to achieve a complete remission followed by an early stem
cell transplantation.
Phase:
Phase 2
Details
Lead Sponsor:
Goethe University Johann Wolfgang Goethe University Hospital